Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

Wall Street Dips as Inflation Worries Resurface
Markets Daniel Marsh

Wall Street Dips as Inflation Worries Resurface

U.S. stocks fell Friday as inflation concerns returned, with consumer prices rising 3.8% in April. The S&P 500 dropped 1.24% to 7,408.50, led by chip stocks and rising Treasury yields.

SPY QQQ XLK XLE GLD SLV USO UNG NVDA AMD INTC
Stocks Slide as Bond Yields Climb, Inflation Fears Resurface
Markets Daniel Marsh

Stocks Slide as Bond Yields Climb, Inflation Fears Resurface

U.S. stocks dropped Friday as rising bond yields and oil prices reignited inflation fears, with the S&P 500 falling 1.2% and the Nasdaq losing 1.5%.

NVDA AMD INTC WMT TGT SPY QQQ USO GLD
Wall Street Pauses as Oil Surge, Yields Temper AI Rally
Markets Daniel Marsh

Wall Street Pauses as Oil Surge, Yields Temper AI Rally

U.S. stocks retreated Friday as higher oil prices and Treasury yields halted the AI-led rally. The S&P 500 fell 1.24%, while the Nasdaq dropped 1.54%, with chip stocks hit hard.

NVDA AMD INTC WMT HD TGT TJX
NextEra-Dominion Merger Talks, Nvidia Earnings, and Retail Reports Set for Busy Week
Markets Daniel Marsh

NextEra-Dominion Merger Talks, Nvidia Earnings, and Retail Reports Set for Busy Week

NextEra Energy and Dominion Energy are in merger talks for a $400B utility, Nvidia reports earnings Wednesday, and major retailers like Walmart and Home Depot release results. Markets await Fed rate decisions.

NEE D NVDA WMT HD TGT TJX DAL M GOOGL MSFT AMZN BA GE DXCM
Global Markets Rally on AI Hype Despite Fragile Economy, Warn Experts
Markets Daniel Marsh

Global Markets Rally on AI Hype Despite Fragile Economy, Warn Experts

Global markets reach new peaks on AI optimism, but economist Paul Sheard cautions that high valuations and concentration risk a severe correction.

BWXT SCCO MELI
Wall Street Slumps as Oil Surge, Yields Jolt AI Rally
Markets Daniel Marsh

Wall Street Slumps as Oil Surge, Yields Jolt AI Rally

U.S. stocks fell more than 1% Friday as oil surged and Treasury yields climbed, pressuring AI stocks and raising Fed rate hike concerns.

DIA SPY QQQ NVDA AMD INTC MSFT AAPL MU TSLA DAL M AMZN UNH V MA GOOGL BRK.B IWM
Origin Materials Shares Surge on Liquidation Plan with Estimated Payout of Up to $3.54
Markets Daniel Marsh

Origin Materials Shares Surge on Liquidation Plan with Estimated Payout of Up to $3.54

Origin Materials shares jumped 15% after disclosing a liquidation plan with estimated payouts of $0.61 to $3.54 per share, as the company cuts 59% of staff and the CEO steps down.

ORGN
Broadcom Leads AI Chip Slide as Inflation Fears Resurface
Markets Daniel Marsh

Broadcom Leads AI Chip Slide as Inflation Fears Resurface

Broadcom shares dropped 3.3% on Friday, leading a broad decline in AI chip stocks as rising oil prices and Treasury yields reignited inflation fears.

AVGO NVDA AMD MRVL
Alphabet Falls as Ackman Exits, Tech Stocks Slide on Oil and Yield Pressure
Markets Daniel Marsh

Alphabet Falls as Ackman Exits, Tech Stocks Slide on Oil and Yield Pressure

Alphabet shares fell 1.1% after Pershing Square sold its stake to fund a Microsoft position, while tech stocks slumped on rising oil and yields.

GOOGL GOOG MSFT AMZN META BRK.B
Berkshire Hathaway Reveals $55M Stake in Macy's, Shares Surge
Markets Daniel Marsh

Berkshire Hathaway Reveals $55M Stake in Macy's, Shares Surge

Berkshire Hathaway's $55 million stake in Macy's sent shares up 5.9% in after-hours trading. The retailer declared a quarterly dividend and faces tariff headwinds.

M BRK.B DAL GOOGL AMZN UNH V MA
Devon Energy Rises on Oil Price Surge and $8B Buyback Approval
Markets Daniel Marsh

Devon Energy Rises on Oil Price Surge and $8B Buyback Approval

Devon Energy shares climbed 4.76% on Friday to $49.49, buoyed by rising oil prices and an $8 billion buyback plan. The stock remains below its 52-week high of $52.71.

DVN OXY EOG FANG USO
Tonix Pharma Surges on Promising Lyme Antibody Data; Phase 2 Trial Eyed for 2027
Markets Daniel Marsh

Tonix Pharma Surges on Promising Lyme Antibody Data; Phase 2 Trial Eyed for 2027

Tonix Pharmaceuticals shares rose after new Phase 1 modeling data for its Lyme antibody TNX-4800 showed six-month protection with two doses. A Phase 2 trial is targeted for 2027.

TNXP PFE VNRX